Insider Selling: Simulations Plus, Inc. (NASDAQ:SLP) Director Sells 3,250 Shares of Stock

Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) Director Daniel L. Weiner sold 3,250 shares of the business's stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $48.31, for a total transaction of $157,007.50. Following the completion of the sale, the director now directly owns 8,759 shares in the company, valued at approximately $423,147.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Simulations Plus Price Performance

Shares of Simulations Plus stock traded down $0.53 during trading on Wednesday, hitting $48.01. The company's stock had a trading volume of 57,254 shares, compared to its average volume of 107,099. Simulations Plus, Inc. has a 52 week low of $32.69 and a 52 week high of $52.69. The stock has a market cap of $959.48 million, a price-to-earnings ratio of 91.58 and a beta of 0.68. The stock has a 50-day moving average price of $44.28 and a two-hundred day moving average price of $41.32.

Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its quarterly earnings data on Wednesday, April 3rd. The technology company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.02. Simulations Plus had a net margin of 16.22% and a return on equity of 7.95%. The company had revenue of $18.31 million for the quarter, compared to analysts' expectations of $17.31 million. During the same quarter in the previous year, the firm posted $0.20 earnings per share. Simulations Plus's revenue for the quarter was up 16.2% on a year-over-year basis. On average, equities analysts predict that Simulations Plus, Inc. will post 0.67 EPS for the current fiscal year.

Simulations Plus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, May 6th. Investors of record on Monday, April 29th were paid a $0.06 dividend. The ex-dividend date of this dividend was Friday, April 26th. This represents a $0.24 annualized dividend and a dividend yield of 0.50%. Simulations Plus's dividend payout ratio is 45.28%.

Institutional Trading of Simulations Plus

A number of large investors have recently bought and sold shares of the business. Victory Capital Management Inc. bought a new stake in Simulations Plus in the third quarter worth approximately $57,000. Kayne Anderson Rudnick Investment Management LLC increased its stake in shares of Simulations Plus by 194.5% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,487 shares of the technology company's stock valued at $62,000 after acquiring an additional 982 shares in the last quarter. Allspring Global Investments Holdings LLC acquired a new position in shares of Simulations Plus during the 1st quarter valued at $70,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Simulations Plus by 74.1% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,446 shares of the technology company's stock valued at $144,000 after acquiring an additional 1,467 shares during the period. Finally, Connecticut Wealth Management LLC bought a new position in Simulations Plus during the first quarter worth $204,000. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.